Division of Aging Biology Funding Opportunity Announcements
DAB is currently seeking applications in response to funding opportunity announcements in the biology of aging and in geroscience. Please see below for active FAO developed by DAB or joined by DAB. DAB also seeks applications related to Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD) in some specific areas.
The full list of NIA-wide active funding opportunities and NIA-wide AD/ADRD funding opportunities can be found online. Read NIA's research and funding frequently asked questions.
The table below contains funding opportunity announcements that are currently being funded in full or in part by the Division of Aging Biology (DAB). The FOAs are grouped by RFA, PAR, then PA, and listed in ascending order of the expiration date.
| FOA Number | Title | Released | Expires | DAB Contact |
|---|---|---|---|---|
| Conference Grants to Advance Collaborative Research on Aging Biology (R13) | 19-May-15 | 08-May-18 | José Velázquez, Ph.D | |
| T2 Translational Research: Research Leading to New Health Care Practices, Community Programs and Policies Affecting Older Persons (R21 Clinical Trial Optional) | 17-Nov-17 | 08-Sep-18 | Rebecca A. Fuldner, Ph.D | |
| T1 Translational Research: Novel Interventions for Prevention and Treatment of Age-related Conditions (R21 Clinical Trial Optional) | 17-Nov-17 | 08-Sep-18 | Rebecca A. Fuldner, Ph.D | |
| T2 Translational Research: Research Leading to New Health Care Practices, Community Programs and Policies Affecting Older Persons (R21) | 28-Apr-15 | 08-Sep-18 | Rebecca A. Fuldner, Ph.D | |
| T1 Translational Research: Novel Interventions for Prevention and Treatment of Age-related Conditions (R21) | 28-Apr-15 | 08-Sep-18 | Rebecca A. Fuldner, Ph.D | |
| T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional) | 28-Nov-17 | 06-Sep-19 | Rebecca A. Fuldner, Ph.D | |
| T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44) | 22-Jul-16 | 06-Sep-19 | Rebecca A. Fuldner, Ph.D | |
| Phenotypic and Functional Characterization of ApoE2 to Inform Translation Strategies for Aging-Related Conditions (R21) | 15-Jul-16 | 08-Sep-19 | Max Guo, Ph.D | |
| Phenotypic and Functional Characterization of ApoE2 to Inform Translation Strategies for Aging-Related Conditions (R01) | 15-Jul-16 | 08-Sep-19 | Max Guo, Ph.D | |
| Role of Age-Associated Metabolic Changes in Alzheimer's Disease (AD) (R01) | 25-Oct-16 | 06-Oct-19 | Yih-Woei Fridell, Ph.D | |
| Dynamic Interactions between Systemic or Non-Neuronal Systems and the Brain in Aging and in Alzheimers Disease (R01) | 21-Oct-16 | 06-Nov-19 | Rebecca Fuldner, Ph.D | |
| Comparative Biology of Neurodegeneration (R21) | 27-Oct-16 | 08-Jan-20 | Francesca Macchiarini, Ph.D | |
| Testing Lifespan-Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R41/R42 Clinical Trial Not Allowed) | 20-Dec-17 | 06-Jan-21 | Max Guo, Ph.D | |
| Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed) | 20-Dec-17 | 06-Jan-21 | Max Guo, Ph.D | |
| Mechanisms Mediating Osteoarthritis in Aging (R21) | 09-May-16 | 08-Sep-19 | John Williams, Ph.D | |
| Mechanisms Mediating Osteoarthritis in Aging (R01) | 09-May-16 | 08-Sep-19 | John Williams, Ph.D | |
| Changes in Cellular Architecture During Aging (R01) | 22-Sep-16 | 08-Jan-20 | Jose Velazquez, Ph.D | |
| Underactive Bladder and Detrusor Activity in Aging (R21 Clinical Trial Optional) | 11-Jan-18 | 08-May-21 | Candace L. Kerr, Ph.D | |
| Underactive Bladder and Detrusor Activity in Aging (R03 Clinical Trial Optional) | 11-Jan-18 | 08-May-21 | Candace L. Kerr, Ph.D | |
| Underactive Bladder and Detrusor Activity in Aging (R01 Clinical Trial Optional) | 11-Jan-18 | 08-May-21 | Candace L. Kerr, Ph.D | |
| Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional). | 3-Apr-18 | 8-May-21 | Francesca Macchiarini, Ph.D | |
| Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional). | 3-Apr-18 | 8-May-21 | Francesca Macchiarini, Ph.D |